IUIS-SITC Primer on Cancer Immunotherapy
In collaboration with the International Union of Immunological Societies (IUIS), the Society for Immunotherapy of Cancer (SITC) presents the IUIS-SITC Primer on Cancer Immunotherapy, which will take place prior to the 18th International Congress of Immunology (IUIS) in Cape Town South Africa on Monday, November 27.
The multisession program will provide a foundation for the basic mechanisms of cancer immunotherapy. The agenda includes topics such as the immune cycle, the TME, clinical cancer immunotherapy, cancer vaccines, combination therapies, and cell therapies.
Target Audience:
The target audience for the IUIS-SITC Primer Session is international immunologists who may not be familiar with immunological approaches to cancer treatment.
Organizer:
Bernard Fox, PhD – Earle A. Chiles Research Institute
Faculty:
Bernard Fox, PhD – Earle A. Chiles Research Institute
Thomas Gajewski, MD, PhD – University of Chicago
Shawn M. Jensen, PhD – Earle A Chiles Research Institute–
Portland Providence Medical Center
Miriam Merad, MD, PhD – Icahn School of Medicine at Mount Sinai
For more information on the program, click below.